Artificial intelligence could revolutionize ARDS diagnosis and treatment
NCT ID NCT07328997
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study tested an artificial intelligence model that analyzes chest CT scans to help diagnose and manage Acute Respiratory Distress Syndrome (ARDS). Researchers used data from 400 ICU patients to train the AI to classify ARDS severity, recommend treatments, and predict 28-day survival. The goal is to give doctors a faster, more accurate tool to guide critical care decisions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
CT scan
What this could lead to
If successful, this AI model could help doctors more accurately diagnose ARDS severity and choose the right treatments faster, potentially improving patient outcomes.
What could go wrong
This is a completed study using existing data, so the model's real-world performance in new patients is not yet proven. The AI may not work as well outside the study's specific hospital setting.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARDS (ACUTE RESPIRATORY DISTRESS SYNDROME) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of critical care medicine, Zhongshan Hospital, Fudan University
Shanghai, Fengling Rd, 200032, P. R., China